Calorie Restriction Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Calorie Restriction (CR) refers to a dietary intervention that reduces daily caloric intake by 20-40% without malnutrition. This approach has been shown to extend lifespan and healthspan in multiple species and is being investigated as a potential therapy for neurodegenerative diseases including Alzheimer's Disease (AD), Parkinson's Disease (PD), and others. Intermittent fasting (IF) and time-restricted eating (TRE) are popular CR variants that may provide similar benefits with less strict adherence requirements.
- Reduced glucose, increased ketones: Metabolic shift from glucose to ketone bodies as fuel
- Ketone bodies (β-hydroxybutyrate): Neuroprotective, reduces oxidative stress
- Enhanced mitochondrial function: Improved ATP production efficiency
- Activated SIRT1: NAD+-dependent deacetylase with anti-aging effects
- mTOR inhibition: Reduces mTORC1 activity, promotes autophagy
- Enhanced clearance: Removal of damaged proteins and organelles
- Reduced protein aggregation: Lower Aβ, α-syn, and mutant huntingtin accumulation
- Mitophagy: Selective removal of damaged mitochondria
- Reduced IGF-1: Lower insulin-like growth factor signaling
- Increased AMPK: Enhanced cellular energy sensing
- Improved insulin sensitivity: Reduced insulin resistance
- Lower fasting insulin: Associated with reduced AD risk
- Reduced microglial activation: Lower pro-inflammatory cytokines
- NLRP3 inflammasome inhibition: Reduced IL-1β production
- Lower systemic inflammation: Reduced CRP, IL-6 levels
- Enhanced antioxidant defenses: Upregulated Nrf2 pathway
- Reduced ROS production: Less mitochondrial damage
- Increased longevity genes: SIRT1, FOXO activation
- Enhanced neurogenesis: Particularly in hippocampus
- Improved LTP: Long-term potentiation
- Better memory consolidation: Especially in aged individuals
- CR improves cognitive function in MCI patients
- May reduce Aβ burden in animal models
- Ketogenic approaches show cognitive benefits
- Human studies ongoing with IF and TRE
- Fasting may protect dopaminergic neurons
- IF reduces motor symptoms in some PD patients
- May enhance autophagy for α-syn clearance
- Caloric restriction may improve levodopa response
- CR extends lifespan in mice (up to 40%)
- Reduces Aβ and tau pathology in AD models
- Protects against MPTP (PD model)
- Reduces protein aggregates in HD models
- 20-40% reduction in daily calories
- Daily restriction of all foods
- Most effective but difficult to maintain
- 5:2 Diet: 5 days normal, 2 days restricted (500-600 cal)
- Alternate Day Fasting: Every other day restriction
- 24-hour Fasting: 1-2 days per week
- 16:8: 16-hour fast, 8-hour eating window
- 14:10: 14-hour fast, 10-hour eating window
- Easier adherence than daily CR
- Very low calorie for 5 days
- Monthly cycles
- May provide CR benefits without prolonged fasting
| Approach |
Duration |
Calorie Reduction |
| Daily CR |
Ongoing |
20-25% |
| 16:8 TRE |
Daily |
~15-20% |
| 5:2 IF |
Weekly |
25% (2 days) |
| FMD |
Monthly (5 days) |
50-70% (5 days) |
- Start gradually (10% reduction)
- Monitor for adverse effects
- Ensure adequate nutrition
- Medical supervision for elderly
- Underweight (BMI <18.5)
- Eating disorders
- Uncontrolled diabetes
- Pregnancy/breastfeeding
- Alzheimer's disease prevention
- Parkinson's disease
- Age-related cognitive decline
- Metabolic syndrome
- Cardiovascular risk reduction
- Weight loss
- Improved insulin sensitivity
- Reduced blood pressure
- Lower cardiovascular risk
- Difficulty maintaining long-term
- Social isolation
- Potential muscle loss
- Nutrient deficiencies if not careful
- Optimal CR degree for neuroprotection
- Personalized CR based on genetics
- Combination with exercise
- Pharmacological CR mimetics
- Long-term safety studies
The study of Calorie Restriction Therapy For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mattson MP, et al. Meal size and frequency affect neuronal plasticity and vulnerability to disease. Nat Rev Neurosci. 2013;14(7):437-451.
- Longo VD, et al. Fasting: Molecular mechanisms and clinical applications. Cell. 2014;156(4):730-744.
- Witte AV, et al. Calorie restriction improves memory in elderly humans. Proc Natl Acad Sci U S A. 2009;106(4):1255-1260.
- Halagappa VK, et al. Intermittent fasting and caloric restriction ameliorate age-related motor deficits in mice. Exp Neurol. 2007;207(1):212-217.
- Anson RM, et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci U S A. 2003;100(10):6216-6220.